1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 34921960 | The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma. | 2022 Mar | 1 |